Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akebia Therapeutics Inc (NASDAQ:AKBA)

8.57
Delayed Data
As of Dec 09
 +0.05 / +0.59%
Today’s Change
7.00
Today|||52-Week Range
13.20
-33.67%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close8.52
Today’s open8.61
Day’s range8.53 - 8.79
Volume117,382
Average volume (3 months)153,036
Market cap$328.4M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+71.52%
Earnings growth (this year)-62.63%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.01

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...+0.14+2.83%
NLNKNewLink Genetics Cor...+0.13+1.18%
ARNAArena Pharmaceutical...+0.04+2.92%
SRNESorrento Therapeutic...-0.05-0.92%
Data as of 4:14pm ET, 12/09/2016

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)-$1.11
Annual revenue (last year)$0.00
Annual profit (last year)-$60.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
John P. Butler
CFO, Treasure, SVP &
Principal Accounting Officer
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs